BioCardia, Inc. Cash And Cash Equivalents At Carrying Value

• BioCardia, Inc. showed an increase of +5.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
• XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2009 to 2025), BioCardia, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 49.8%.
• Historical annual values: Fiscal year 2025: $2.50 million | Fiscal year 2024: $2.37 million | Fiscal year 2023: $1.10 million | Fiscal year 2022: $7.36 million | Fiscal year 2021: $12.87 million | Fiscal year 2020: $21.41 million | Fiscal year 2019: $5.59 million | Fiscal year 2018: $5.36 million | Fiscal year 2017: $12.69 million | Fiscal year 2016: $21.35 million | Fiscal year 2016: $24.00 million | Fiscal year 2015: $3.56 million | Fiscal year 2014: $3.18 million | Fiscal year 2013: $13.30 million | Fiscal year 2012: $13.27 million | Fiscal year 2012: $12.82 million | Fiscal year 2011: $12.68 million | Fiscal year 2010: $127.0 thousand | Fiscal year 2009: $4.97 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026